Deal news: advising Philips on sale of its PathXL business

Deal news: advising Philips on sale of its PathXL business

Stevens & Bolton has advised Philips of the sale of its Belfast-based Digital and Computational Pathology business, formerly known as PathXL, to medical informatics and image technology company, Cirdan.

PathXL was founded in 2004 as a Queen’s University Belfast spin out company and was purchased by Philips in 2016. It offers a range of digital pathology software applications for research and education addressing growing segments of the pathology market including bio-pharma.

The Stevens & Bolton team was led by corporate partner Keith Syson, supported by Nassar Nassar (corporate), Kate Schmit (corporate tax), Kerry Garcia and Abigail Etchells (employment).

Contact our experts for further advice

View profile for Keith SysonKeith Syson

Search our site